Glaxo Group Limited Trademarks (3671 records)

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners listed on this page.

Company Trademark Status Update Alerts are email updates of the latest trademarks' status change on company level. Click here to get the alert for FREE!

Hot News! On Tuesday, June 20, 2017, a U.S. federal trademark registration number 87498127 was filed for ZOQUABI by Glaxo Group Limited with the description (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines.

Hot News! On Tuesday, June 20, 2017, a U.S. federal trademark registration number 87498131 was filed for JATOLPIA by Glaxo Group Limited with the description (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines.

Abandonment Notice! On Friday, July 7, 2017, a U.S. federal trademark for Glaxo Group Limited registration number 77626815 was abandoned having the name TAKE CONTROL OF ASTHMA. The Reason provided as CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE. Apply Now for this name, Starts at $199!

Abandonment Notice! On Friday, June 30, 2017, a U.S. federal trademark for Glaxo Group Limited registration number 77626825 was abandoned having the name TOME EL CONTROL DEL ASMA. The Reason provided as CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE. Apply Now for this name, Starts at $199!

Abandonment Notice! On Monday, July 3, 2017, a U.S. federal trademark for Glaxo Group Limited registration number 86117943 was abandoned having the name KIBLOK. The Reason provided as ABANDONED - NO STATEMENT OF USE FILED. Apply Now for this name, Starts at $199!

Abandonment Notice! On Monday, July 3, 2017, a U.S. federal trademark for Glaxo Group Limited registration number 86118067 was abandoned having the name ALBODE. The Reason provided as ABANDONED - NO STATEMENT OF USE FILED. Apply Now for this name, Starts at $199!